These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15334700)

  • 21. Oxaliplatin, irinotecan and cetuximab in advanced gastric cancer. A multicenter phase II trial (Gastric-2) of the Arbeitsgemeinschaft Medikamentose Tumortherapie (AGMT).
    Wöll E; Greil R; Eisterer W; Bechter O; Fridrik MA; Grünberger B; Zabernigg A; Mayrbäurl B; Russ G; Dlaska M; Obrist P; Thaler J
    Anticancer Res; 2011 Dec; 31(12):4439-43. PubMed ID: 22199312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA polymerase η protein expression predicts treatment response and survival of metastatic gastric adenocarcinoma patients treated with oxaliplatin-based chemotherapy.
    Teng KY; Qiu MZ; Li ZH; Luo HY; Zeng ZL; Luo RZ; Zhang HZ; Wang ZQ; Li YH; Xu RH
    J Transl Med; 2010 Nov; 8():126. PubMed ID: 21110884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mechanisms of oxaliplatin-induced apoptosis of human multiple myeloma cell RPMI8226].
    Liu BL; Liu X; Zhou NC; Qi MY; Xu B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):99-104. PubMed ID: 23484700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients.
    De Vita F; Orditura M; Matano E; Bianco R; Carlomagno C; Infusino S; Damiano V; Simeone E; Diadema MR; Lieto E; Castellano P; Pepe S; De Placido S; Galizia G; Di Martino N; Ciardiello F; Catalano G; Bianco AR
    Br J Cancer; 2005 May; 92(9):1644-9. PubMed ID: 15856038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of XELOX regimen as neoadjuvant chemotherapy on radical resection rate and prognosis in patients with advanced gastric cancer].
    Zhao Q; Li Y; Tan BB; Tian Y; Jiao ZK; Zhao XF; Zhang ZD; Wang D; Yang PG
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):773-7. PubMed ID: 24378101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Impact of S100P expression on clinical outcomes of gastric cancer patients with adjuvant chemotherapy of oxaliplatin and its mechanisms].
    Zhao XM; Bai ZG; Ma XM; Zhang ZT; Shi XY
    Zhonghua Wai Ke Za Zhi; 2010 Jul; 48(13):1004-8. PubMed ID: 21054985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The treatment of retinal apoptosis by Caspase 3 inhibitor Ac-DEVD-CHO in experimental myopia].
    Liu SZ; Mao JF; Wen D; Tan XP; Fu CY
    Zhonghua Yan Ke Za Zhi; 2005 May; 41(5):428-33. PubMed ID: 15938808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical results of advanced gastric cancer patients treated with oxaliplatin-containing regimen].
    Zhang WM; Xu GH; Ju AP; Zheng YT; Jiang Q
    Ai Zheng; 2003 Dec; 22(12):1346-8. PubMed ID: 14693066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caspase-3 inhibitor transiently delays inherited retinal degeneration in C3H mice carrying the rd gene.
    Yoshizawa K; Kiuchi K; Nambu H; Yang J; Senzaki H; Kiyozuka Y; Shikata N; Tsubura A
    Graefes Arch Clin Exp Ophthalmol; 2002 Mar; 240(3):214-9. PubMed ID: 11935279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased anticancer activity of the thymidylate synthase inhibitor BGC9331 combined with the topoisomerase I inhibitor SN-38 in human colorectal and breast cancer cells: induction of apoptosis and ROCK cleavage through caspase-3-dependent and -independent mechanisms.
    Coudray AM; Louvet C; Kornprobst M; Raymond E; André T; Tournigand C; Faivre S; De Gramont A; Larsen AK; Gespach C
    Int J Oncol; 2005 Aug; 27(2):553-61. PubMed ID: 16010439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diallyl trisulfide induces apoptosis of human gastric cancer cell line MGC803 through caspase-3 pathway].
    Xiao XL; Peng J; Su Q; Xiang SL; Tang GH; Huang YS; Zhou XT
    Ai Zheng; 2006 Oct; 25(10):1247-51. PubMed ID: 17059769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer Xenografts.
    Nukatsuka M; Nakagawa F; Takechi T
    Anticancer Res; 2015 Sep; 35(9):4605-15. PubMed ID: 26254349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: a retrospective analysis.
    Seo HY; Kim DS; Choi YS; Sung HJ; Park KH; Choi IK; Kim SJ; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
    Cancer Chemother Pharmacol; 2009 Feb; 63(3):433-9. PubMed ID: 18398608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer.
    Sym SJ; Ryu MH; Kang HJ; Lee SS; Chang HM; Lee JL; Kim TW; Yook JH; Oh ST; Kim BS; Kang YK
    Cancer Chemother Pharmacol; 2010 Jul; 66(2):373-80. PubMed ID: 19936751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-acetyl cysteine inhibits human signet ring cell gastric cancer cell line (SJ-89) cell growth by inducing apoptosis and DNA synthesis arrest.
    Li J; Tu HJ; Li J; Dai G; Dai YC; Wu Q; Shi QZ; Cao Q; Li ZJ
    Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):769-74. PubMed ID: 17700262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Oxaliplatin in combination with calcium folinate and fluorouracil as neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
    Fang Y; Wang YJ; Li F; Li J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):510-2. PubMed ID: 17143797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
    Gu WJ; Liu HL
    Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Introduction of oxaliplatin for treating unresectable advanced or recurrent gastric cancer in clinical practice].
    Sato A
    Gan To Kagaku Ryoho; 2015 Apr; 42(4):443-6. PubMed ID: 25963690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P38 Signal Transduction Pathway Has More Cofactors on Apoptosis of SGC-7901 Gastric Cancer Cells Induced by Combination of Rutin and Oxaliplatin.
    Li Q; Ren L; Zhang Y; Gu Z; Tan Q; Zhang T; Qin M; Chen S
    Biomed Res Int; 2019; 2019():6407210. PubMed ID: 31781632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic enhancement of the antitumor activity of 5-fluorouracil by bornyl acetate in SGC-7901 human gastric cancer cells and the determination of the underlying mechanism of action.
    Li J; Wang SX
    J BUON; 2016; 21(1):108-17. PubMed ID: 27061538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.